S
Saaeha Rauz
Researcher at University of Birmingham
Publications - 149
Citations - 4424
Saaeha Rauz is an academic researcher from University of Birmingham. The author has contributed to research in topics: Medicine & Uveitis. The author has an hindex of 36, co-authored 132 publications receiving 3737 citations. Previous affiliations of Saaeha Rauz include Moorfields Eye Hospital & Frimley Park Hospital.
Papers
More filters
Journal ArticleDOI
Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study
Shouvik Dass,Simon J. Bowman,Edward M Vital,Kei Ikeda,Colin T. Pease,John Hamburger,Andrea Richards,Saaeha Rauz,Paul Emery +8 more
TL;DR: This is the first double blind, placebo-controlled, randomised pilot study of the efficacy of rituximab in reducing fatigue in Primary Sjögren syndrome to show benefit.
Journal ArticleDOI
Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study.
Alexandra J Sinclair,Michael A. Burdon,Peter Nightingale,A. K. Ball,Peter Good,Timothy D Matthews,Andrew S. Jacks,Mark Lawden,Carl E Clarke,Paul M. Stewart,Elizabeth A. Walker,Jeremy W. Tomlinson,Saaeha Rauz +12 more
TL;DR: Women with idiopathic intracranial hypertension who followed a low energy diet for three months had significantly reduced intrac Cranial pressure compared with pressure measured in the three months before the diet, as well as improved symptoms and reduced papilloedema.
Journal ArticleDOI
Multiplex Bead Immunoassay Analysis of Aqueous Humor Reveals Distinct Cytokine Profiles In Uveitis
S. John Curnow,Francesco Falciani,Omar M. Durrani,C. M. Gemmy Cheung,Emma J. Ross,Kaska Wloka,Saaeha Rauz,Graham R. Wallace,Mike Salmon,Philip I. Murray +9 more
TL;DR: Idiopathic uveitis AqH was characterized by high levels of IL-6, IL-8, CCL2 and IFNgamma, the levels of which correlated with each other, and distinct patterns of cytokines that relate to both clinical disease and the cellular infiltrates present were identified.
Journal ArticleDOI
Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis.
Stefano Bonini,Alessandro Lambiase,Paolo Rama,Francesco Sinigaglia,Marcello Allegretti,Wendy Chao,Flavio Mantelli,Elisabeth M. Messmer,Pasquale Aragona,Gerd Geerling,Leonardo Mastropasqua,Rita Mencucci,John K G Dart,Andrea Leonardi,Jesús Montero,Maurizio Rolando,Thomas Reinhard,Claus Cursiefen,Jaime Etxebarria,Eric E. Gabison,Jacek P. Szaflik,Nacim Bouheraoua,Maria De La Paz,Maite Sainz de la Maza,Edward Wylegala,Francisco C Figueiredo,Paolo Fogagnolo,Parwez Hossain,Katrin Lorenz,Pierre-Yves Robert,Jose M. Benitez del Castillo,Catherine Creuzot-Garcher,Friedrich E. Kruse,François Malecaze,Jesus Merayo-Lloves,Saaeha Rauz,Jorge L. Alió,Fiona Carley,Ramaesh Kanna,Carina Koppen,János Németh,Joaquim Murta,Luis Torrao +42 more
TL;DR: Topical rhNGF is safe and more effective than vehicle in promoting healing of moderate-to-severe NK, a rare degenerative corneal disease resulting from impairedCorneal innervation.
Journal ArticleDOI
NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases--a diagnostic tool?
Alexandra J Sinclair,Mark R. Viant,A. K. Ball,Michael A. Burdon,Elizabeth A. Walker,Paul M. Stewart,Saaeha Rauz,Stephen P. Young +7 more
TL;DR: The objective was to evaluate the diagnostic accuracy of metabolomic biomarker profiles in neurological conditions (idiopathic intracranial hypertension, multiple sclerosis and cerebrovascular disease) compared to controls with either no neurological disease or mixed neurological diseases.